Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- Disease-free survival
研究概览
简要总结
This prospective, single-institution, observational study explores disease outcomes and toxicities in subjects with gastrointestinal malignancies and sarcoma (bone and soft tissue) who are being treated with standard-of-care therapies including radiotherapy.
Recent advances in treatment approaches affected disease outcomes and toxicities. Prospective monitoring of disease outcomes and toxicities using standardized assessments will provide information about recent changes in the standard of care and further refine treatment approaches and prospective clinical trial design.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Disease-free survival
时间窗: Up to 10 years
Disease-free survival is defined as the length of time after treatment in which the subject survives with no signs or symptoms of cancer.
次要结局
- Quality of life Toronto Extremity Salvage Score (TESS)(Up to 10 years)
- Quality of life PRO-CTCAE(Up to 10 years)
- Local Control(Up to 10 years)
- Adverse Events(Up to 10 years)
- Quality of life EQ-5D-5L(Up to 10 years)